Company Celsion Corporation Nasdaq
Equities
US15117N4043
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
05-13 | Transcript : Imunon, Inc., Q1 2024 Earnings Call, May 13, 2024 | |
05-08 | IMUNON, Inc. Appoints Stacy R. Lindborg as Chief Executive Officer, Effective May 13, 2024 | CI |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Stacy Lindborg
CEO | Chief Executive Officer | 53 | 21-06-03 |
Michael Tardugno
CHM | Chairman | 73 | 07-01-02 |
Jeffrey Church
DFI | Director of Finance/CFO | 67 | 10-07-05 |
Sebastien Hazard
CTO | Chief Tech/Sci/R&D Officer | 53 | 12-10 |
Khursheed Anwer
CTO | Chief Tech/Sci/R&D Officer | 64 | 14-06-19 |
Kimberly Bragg
AUD | Comptroller/Controller/Auditor | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 56 | 21-06-07 | |
Frederick Fritz
BRD | Director/Board Member | 73 | 11-07-07 |
James Dentzer
BRD | Director/Board Member | 57 | 22-09-02 |
Michael Tardugno
CHM | Chairman | 73 | 07-01-02 |
Donald Braun
BRD | Director/Board Member | 74 | 15-12-14 |
Stacy Lindborg
CEO | Chief Executive Officer | 53 | 21-06-03 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 9,400,911 | 9,291,441 ( 98.84 %) | 0 | 98.84 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+7.96% | 113B | |
+10.29% | 106B | |
+0.41% | 22.27B | |
-12.07% | 22.22B | |
-5.99% | 19.43B | |
-37.36% | 17.87B | |
-5.74% | 17.24B | |
+7.15% | 14.29B | |
+36.67% | 12.52B |
- Stock Market
- Equities
- IMNN Stock
- Stock
- Company Celsion Corporation